Benzinga
Benzinga
Benzinga
mardi, septembre 15

Acurx Pharmaceuticals Inc

ACXPNASDAQ
Trade with Public
Trade with Public
$1.39
-0.01-0.71%
À la clôture: Sep 14, 5:00 PM EST
$1.40
0.010.72%
Après les heures: 7:55 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

Acurx Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Acurx Pharmaceuticals (ACXP).

Price Target Range — 8 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$144Upside to Avg. PT+10162.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 30, 2025HC Wainwright & Co.Matthew KellerMaintainedBuy$31
Aug 12, 2025HC Wainwright & Co.Matthew KellerPT RaiseBuy$8→$31
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $31 Price Target

HC Wainwright & Co. analyst Matthew Keller reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $31 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $31

HC Wainwright & Co. analyst Matthew Keller maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $8 to $31.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Acurx Pharmaceuticals at Buy, Announces Price Target of $8

HC Wainwright & Co. analyst Matthew Kelsey assumes Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved